Sebastian Pünzeler

Sebastian Pünzeler is a Supervisory Board Member at Tubulis. Prior to this, they were a Board Member at Abalos Therapeutics GmbH from September 2021 to July 2022. Sebastian has also served as a Board Observer at Cardior Pharmaceuticals and CatalYm GmbH. Sebastian Pünzeler was also previously with Tubulis GmbH and Tacalyx GmbH as a Board Observer. At Thermosome, they served as a Board Observer from March 2019 to July 2022. Sebastian Pünzeler has also been a Principal at coparion since October 2016.

Sebastian Pünzeler has a Ph.D. in Biochemistry and Molecular Biology from Ludwig-Maximilians-Universität München, a Diplom in Biochemistry and Molecular Biology from Ludwig-Maximilians-Universität München, and a Vordiplom in Biology from RWTH Aachen University. Sebastian also has an MBA Essentials Course from The London School of Economics and Political Science (LSE), and is a member of IMPRS-LS | International Max Planck Research School for Molecular Life Sciences.